These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34895470)

  • 61. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
    Agnew H; Kitson S; Crosbie EJ
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012513. PubMed ID: 36971688
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials.
    de Oliveira Almeida G; Nienkötter TF; Balieiro CCA; Pasqualotto E; Cintra JB; Carvalho HCP; Silva ALS; Kabariti JC; Minucci BS; Bertoli ED; Guida CM
    Am J Cardiovasc Drugs; 2024 Jul; 24(4):509-521. PubMed ID: 38734847
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative effectiveness of glucagon-like peptide-1 receptor agonists on body composition and anthropometric indices: A protocol for a systematic review and network meta-analysis of randomized controlled trials.
    Wachiraphansakul N; Vongchaiudomchoke T; Manosroi W; Nochaiwong S
    PLoS One; 2024; 19(2):e0297488. PubMed ID: 38408098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis.
    Li H; Yu G; Huang Q; Yang B; Nie J; Liu Y; Tu X
    Biomed Pharmacother; 2024 Feb; 171():116150. PubMed ID: 38242040
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Screening for Obesity and Intervention for Weight Management in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    O'Connor EA; Evans CV; Burda BU; Walsh ES; Eder M; Lozano P
    JAMA; 2017 Jun; 317(23):2427-2444. PubMed ID: 28632873
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials.
    Ge L; Sadeghirad B; Ball GDC; da Costa BR; Hitchcock CL; Svendrovski A; Kiflen R; Quadri K; Kwon HY; Karamouzian M; Adams-Webber T; Ahmed W; Damanhoury S; Zeraatkar D; Nikolakopoulou A; Tsuyuki RT; Tian J; Yang K; Guyatt GH; Johnston BC
    BMJ; 2020 Apr; 369():m696. PubMed ID: 32238384
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New obesity agents: lorcaserin and phentermine/topiramate.
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: A protocol for systematic review and meta-analysis.
    Ma R; Ding X; Wang Y; Deng Y; Sun A
    Medicine (Baltimore); 2021 Jun; 100(23):e26295. PubMed ID: 34115034
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis.
    Zhang L; Liu Z; Liao S; He H; Zhang M
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1611-1621. PubMed ID: 34043049
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of glucagon-like peptide 1 receptor agonists in management of obesity.
    Isaacs D; Prasad-Reddy L; Srivastava SB
    Am J Health Syst Pharm; 2016 Oct; 73(19):1493-507. PubMed ID: 27521241
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In adults with overweight or obesity, adding weight-lowering drugs to lifestyle modification improves weight loss.
    Sarma S; Lipscombe L
    Ann Intern Med; 2022 May; 175(5):JC57. PubMed ID: 35500265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis.
    Caruso I; Di Gioia L; Di Molfetta S; Cignarelli A; Palmer SC; Natale P; Strippoli GFM; Perrini S; Natalicchio A; Laviola L; Giorgino F
    EClinicalMedicine; 2023 Oct; 64():102181. PubMed ID: 37719418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials.
    Pan B; Ge L; Lai H; Hou L; Tian C; Wang Q; Yang K; Lu Y; Zhu H; Li M; Wang D; Li X; Zhang Y; Gao Y; Liu M; Ding G; Tian J; Yang K
    Drugs; 2023 May; 83(7):587-619. PubMed ID: 36947394
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
    Kitson S; Ryan N; MacKintosh ML; Edmondson R; Duffy JM; Crosbie EJ
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012513. PubMed ID: 29388687
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials.
    Haber R; Zarzour F; Ghezzawi M; Saadeh N; Bacha DS; Al Jebbawi L; Chakhtoura M; Mantzoros CS
    Diabetes Obes Metab; 2024 May; 26(5):1850-1867. PubMed ID: 38468148
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release.
    Garvey WT; Ryan DH; Bohannon NJ; Kushner RF; Rueger M; Dvorak RV; Troupin B
    Diabetes Care; 2014 Dec; 37(12):3309-16. PubMed ID: 25249652
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 2 new drugs for weight loss.
    Med Lett Drugs Ther; 2012 Sep; 54(1398):69-71. PubMed ID: 22992487
    [No Abstract]   [Full Text] [Related]  

  • 80. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis.
    Oba Y; Anwer S; Patel T; Maduke T; Dias S
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013797. PubMed ID: 37602534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.